Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection

被引:23
作者
Hogan, MC
Gloor, JM
Uhl, JR
Cockerill, FR
Milliner, DS
机构
[1] Mayo Clin, Div Nephrol, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Pediat Nephrol, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
关键词
enterohemorrhagic Escherichia coli; urinary tract infection; Shiga toxins; hemolytic uremic syndrome (HUS); renal failure; end-stage renal disease;
D O I
10.1053/ajkd.2001.27731
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Escherichia coli serotype O157:H7 Is a leading cause of diarrhea and hemolytic uremic syndrome (HUS). Because of the limitations of current diagnostic techniques, the prevalence of non-O157:H7 Shiga toxin-producing E coli strains Is not known. We describe two patients with HUS in whom no E coli O157:H7 was demonstrable In stool cultures. On culture of the urine, the first patient was found to have E coli O113:H21 strain, and the second patient had E coli O6:H1 serotype. Shiga toxin production (stx2) by the O113:H21 Isolate was confirmed. The first patient required 15 days of peritoneal dialysis and subsequently recovered renal function. At last follow-up, serum creatinine was 0.9 mg/dL. The second patient had preservation of renal function throughout the acute illness with serum creatinine of 0.5 mg/dL. The clinical presentation, bacteriology, course, and outcome as well as epidemiologic Implications of the Increasing number of patients with E coli urinary tract infections associated with HUS are discussed. These cases Illustrate the need to investigate patients with nondiarrheal HUS for Infection with Shiga toxin-producing E coli of the non-O157 strain variety. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:e22.1 / e22.6
页数:6
相关论文
共 45 条
[1]   THE ROLE OF ESCHERICHIA-COLI O-157 INFECTIONS IN THE CLASSICAL (ENTEROPATHIC) HEMOLYTIC UREMIC SYNDROME - RESULTS OF A CENTRAL-EUROPEAN, MULTICENTER STUDY [J].
BITZAN, M ;
LUDWIG, K ;
KLEMT, M ;
KONIG, H ;
BUREN, J ;
MULLERWIEFEL, DE .
EPIDEMIOLOGY AND INFECTION, 1993, 110 (02) :183-196
[2]   HIGH-INCIDENCE OF SERUM ANTIBODIES TO ESCHERICHIA-COLI O157 LIPOPOLYSACCHARIDE IN CHILDREN WITH HEMOLYTIC-UREMIC SYNDROME [J].
BITZAN, M ;
MOEBIUS, E ;
LUDWIG, K ;
MULLERWIEFEL, DE ;
HEESEMANN, J ;
KARCH, H .
JOURNAL OF PEDIATRICS, 1991, 119 (03) :380-385
[3]   Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults [J].
Bonnet, R ;
Souweine, B ;
Gauthier, G ;
Rich, C ;
Livrelli, V ;
Sirot, J ;
Joly, B ;
Forestier, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (06) :1777-1780
[4]   COMMUNITY-WIDE OUTBREAK OF HEMOLYTIC-UREMIC SYNDROME-ASSOCIATED WITH NON-O157 VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI [J].
CAPRIOLI, A ;
LUZZI, I ;
ROSMINI, F ;
RESTI, C ;
EDEFONTI, A ;
PERFUMO, F ;
FARINA, C ;
GOGLIO, A ;
GIANVITI, A ;
RIZZONI, G .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :208-211
[5]   FAMILIAL HYPOCOMPLEMENTEMIC HEMOLYTIC UREMIC SYNDROME WITH HLA-A3,B7-HAPLOTYPE [J].
CARRERAS, L ;
ROMERO, R ;
REQUESENS, C ;
OLIVER, AJ ;
CARRERA, M ;
CLAVO, M ;
ALSINA, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (06) :602-604
[6]   Escherichia coli O157:H7:: Assessing and minimizing the risk from farm to fork [J].
Cohen, MB .
JOURNAL OF PEDIATRICS, 1998, 132 (05) :756-757
[7]   NEONATAL HEMOLYTIC-UREMIC SYNDROME [J].
FIGUERAS, J ;
ROLDAN, A ;
BOTET, F ;
PALACIN, A ;
JIMENEZ, R .
CLINICAL PEDIATRICS, 1995, 34 (04) :220-222
[8]  
GIANANTONIO CA, 1973, NEPHRON, V11, P174
[9]   An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H-: Or was it? [J].
Goldwater, PN ;
Bettelheim, KA .
EMERGING INFECTIOUS DISEASES, 1996, 2 (02) :153-154
[10]   New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E-coli serotypes in human disease [J].
Goldwater, PN ;
Bettelheim, KA .
JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (12) :1039-1045